AdventHealth
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, AdventHealth sits in the top decile of US sponsors by registered trial count (#248 of 15,742 sponsors by registered trial count).
AdventHealth: 95 sponsored US clinical trials, 16 recruiting.
AdventHealth sponsors 95 registered US clinical trials on ClinicalTrials.gov, 16 of them currently recruiting, and 63 completed. 6 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pancreatic Neoplasms, with 2 trials.
Top-decile sponsor footprint
AdventHealth ranks in the top decile of sponsors by registered trial count (#248 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
63 of 72 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
95 total, page 1 of 2
Methadone in the Management of Post-Operative Pain in Total Knee Replacement
NCT07485803
A Pilot Study of RISE for Nurse Managers Retreat
NCT07298018
A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer
NCT07121738
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
NCT07231159
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
NCT05877885
Exploring the Potential of Robotic Telesurgery in Remote Settings
NCT07130708
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
NCT06631521
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
NCT06617481
A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Hepatopancreaticobiliary and Foregut Operations for Benign and Malignant Disease
NCT06562179
The Treatment of Painful Diabetic Neuropathy With Diet
NCT07509671
Reducing Wound Infections Using Bioelectric Wound Dressings
NCT06312267
Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation
NCT06476145
Comparing Endoscopic Ultrasound vs Surgical Gastrojejunostomy for Management of GOO.
NCT06128018
Evaluation of the Clinical Utility of Endoscopic Closure Using a Dual Action Tissue (DAT) Clip
NCT05852457
Endoscopic Submucosal Dissection (ESD)
NCT05468008
Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
NCT05905016
U-POEM vs CO2-POEM
NCT06918730
RISE for Nurse Preceptors
NCT06822777
Evaluating Learning Curves and Competence in Colorectal Endoscopic Mucosal Resection Among Advanced Endoscopy Trainees
NCT06376006
Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)
NCT02531607
Professional Readiness Through Emotional Preparedness (PREP)
NCT07472127
Comparative Analysis of Hearing Outcomes: Robotic vs. Manual Insertion of Cochlear Implants
NCT07081542
Increasing the Use of Self Measured Home Blood Pressure Logs in the Management of Hypertension
NCT07556783
The LARC Robot Simplifies Renal Access In Percutaneous Nephrolithotomy
NCT07211555
A Prospective Study of RISE for Physicians
NCT06462443
Healthy Eating and Active Lifestyle (HEAL): Breast Cancer Program Outcomes
NCT06078761
Impact of Exercise Intervention on Well-being in Shift-working Acute Care Nurses
NCT05966805
Self-Assembling Matrix Forming Gel to Prevent Stricture Formation
NCT05581173
Donor Breast Milk and Serum Ferritin Levels in Very Preterm Infants
NCT06843278
Hybrid Versus Non-Hybrid Endoscopic Submucosal Dissection for Colorectal Polyps (SHORT-ESD)
NCT05347446
RISE RCT for Nurse Leaders
NCT05254600
A Pilot Study of RISE for Nurse Managers
NCT04987697
Mother's Recorded Voice for Preterm Infants
NCT04559620
Elevation of the Fetal Buttocks Prior to External Cephalic Version
NCT04538261
Reusable Versus Disposable Duodenoscopes for ERCP
NCT04143698
Endoscopic Necrosectomy Versus Step-up Endoscopic Intervention
NCT04113499
Treatment Outcomes in Bile Duct Stones
NCT04145843
Moral Injury Symptom Scale/Moral Injury Outcome Scale
NCT04261751
2 New Measurements Used to Describe the Filling Phase of the Left Ventricle (LV).
NCT04154878
Registry for Upper Gastrointestinal Bleeding
NCT04211194
Endoscopic Ultrasound vs Percutaneous Route for Liver Biopsy
NCT04003766
Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia
NCT03576885
The Development and Evaluation of a Novel Duodenoscope Assessment Tool
NCT04004533
Radiation Exposure Assessment in Fluoroscopy
NCT03985488
Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants
NCT04062851
RISE Program for Nurses
NCT04952441
Exploration of Patient Ethics and Communication Excellence (PEACE) Rounds
NCT03874676
OMILQ: Osteopathic Manipulation to Increase Lactation Quantity (OMILQ)
NCT03875794
Resilience Insight Self Compassion and Empowerment (RISE) Pilot
NCT03645707
Resilience Intervention for Critical Care Nurses
NCT03645512
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 4 | 6 |
Where AdventHealth enrollment is open (later-stage tilt)
16 recruiting of 95 indexed (17% open); 63 completed (66%).
Phase mix: 6 late (III/IV) vs 3 early (I/II) (later-stage heavy).
Top condition: Pancreatic Neoplasms (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
AdventHealth: open-pipeline peers nationwide
Peers matched on 95 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
AdventHealth sits below the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 95 trials (± recruiting share)
- Texas A&M University · 95 trials · 23% recruiting
- Masimo Corporation · 96 trials · 3% recruiting
- University of Mississippi Medical Center · 96 trials · 10% recruiting
- University of Tennessee · 96 trials · 13% recruiting
Sponsors near 17% open enrollment (± trial volume)
- University of Utah · 17% recruiting · 818 trials
- University of Hawaii · 17% recruiting · 77 trials
- Penn State University · 17% recruiting · 219 trials
- CSL Behring · 17% recruiting · 71 trials
Related
What to do with this AdventHealth page
95 registered trials is a research-attention snapshot, not an endorsement of AdventHealth or any single study.
- 16 of AdventHealth's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pancreatic Neoplasms is the condition AdventHealth studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pancreatic Neoplasms trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
AdventHealth pipeline card: 95 registered trials from official public datasets.Report a data error.